Mazen Noureddin, MD, MHSc joins HepaTx’s Scientific Advisory Board

PALO ALTO, Calif. and HOUSTON, March 7, 2023 /PRNewswire/ — HepaTx, a preclinical-stage biotechnology company developing cell therapies for liver diseases, announced today that Mazen Noureddin, MD, MHSc, a renowned expert in the field of hepatology, has joined the company’s Scientific…

Advertisement — Advertise with Biotech Networks